Hero Image

Medicare changes in 2026: What seniors need to know

Big updates are coming to Medicare in 2026, and knowing what’s changing can help you save money and avoid surprises.

Most of these shifts stem from the Inflation Reduction Act (IRA) and ongoing Medicare benefit redesigns that aim to make prescription drugs and premiums more predictable.

At-a-glance: 2026 Medicare changes

Here are five changes seniors can expect to shape costs and coverage in 2026: negotiated prices for some high-spend Part D drugs, a $2,000 annual cap on Part D out-of-pocket costs (with an option to spread payments monthly), continued limits on premium growth, ongoing $35 insulin caps and $0 vaccines, and inflation rebates that help curb drug price hikes.

Bottom line: 2026 should bring more predictable pharmacy bills and steadier premiums, though your exact savings will depend on your medications and plan choices. Review your drugs, compare plans, and take advantage of cost-saving programs to get the most value.

The five Medicare changes to expect in 2026

1) First negotiated drug prices take effect for select Part D drugs

Starting in 2026, Medicare will apply its first negotiated “Maximum Fair Prices” for a set of high-spend Part D drugs. These lower prices are intended to reduce what plans and beneficiaries pay at the pharmacy counter. Not every drug is included—only a limited list qualifies in 2026—but if one of your medications is on it, you could see lower costs at the point of sale. For program details and timelines, see the official CMS page on the Medicare Drug Price Negotiation Program.

What it means for you: Potentially lower out-of-pocket costs if you use a negotiated drug, though savings vary by plan and pharmacy. Not all formulations or strengths may be included, and plans may adjust formularies in response.

  • Do this: Make a list of your medications, including dose and frequency. During open enrollment, check your plan’s 2026 formulary and estimated costs.
  • Ask your pharmacist/doctor: Whether a negotiated alternative is appropriate if your current drug isn’t on the list.

2) Part D’s $2,000 annual cap remains—and you can spread costs monthly

Beginning in 2025, Part D introduced a $2,000 annual cap on out-of-pocket prescription drug costs. That cap continues in 2026. Also continuing: the new Prescription Payment Plan (often called “smoothing”), which lets you opt in to spread your out-of-pocket Part D costs in equal monthly amounts across the year instead of paying large amounts all at once.

What it means for you: If your drug costs are high, you won’t pay more than $2,000 out of pocket in 2026 for Part D drugs. Smoothing can help cash flow—especially early in the year—by converting big refill bills into predictable monthly payments.

  • Do this: Estimate your 2026 drug spending. If you expect high costs, contact your plan to ask how to enroll in the monthly payment option and what to expect if you switch plans midyear.
  • Watch for: Auto-debit rules, missed payment policies, and how refunds/credits work if you change drugs or reach the cap.

3) Part D premium growth is limited by law

Through the end of the decade, federal law limits annual increases in the base beneficiary premium for Part D. While this doesn’t freeze the exact premium you pay for your specific plan, it’s designed to keep average premiums steadier than they might otherwise be.

What it means for you: Expect fewer sharp swings in the underlying premium benchmark. However, individual plan premiums can still go up or down depending on benefits and plan design, so it’s important to compare options every year.

  • Do this: Don’t auto-renew blindly. Use the Medicare Plan Finder to compare 2026 premiums, copays, and drug coverage during open enrollment (Oct 15–Dec 7).
  • Check your mail: Review your plan’s Annual Notice of Change (ANOC) to see if premiums or benefits are changing.

4) $35 insulin copays and $0 adult vaccines continue

The $35 monthly cap for covered insulin (under Part D, and for insulin furnished through pumps under Part B) remains in effect, and ACIP-recommended adult vaccines covered by Part D (like shingles and Tdap) continue at $0 cost sharing. These provisions reduce out-of-pocket costs for millions of beneficiaries.

What it means for you: If you take insulin, you should not pay more than $35 for a month’s supply of each covered insulin product. Recommended adult vaccines covered by your Part D plan should have no copay or deductible.

  • Do this: Confirm that your brand and formulation of insulin are on your plan’s formulary and that your pharmacy is in network.
  • Ask your pharmacist: About scheduling vaccines you’ve missed; they should be covered at $0 when billed to Part D.

5) Inflation rebates help curb price hikes (and may lower some Part B coinsurance)

Drug manufacturers owe rebates to Medicare when prices for many Part B and Part D drugs rise faster than inflation. For certain Part B drugs, these rebates can translate into lower beneficiary coinsurance for affected quarters. The program continues in 2026.

What it means for you: You may see reduced coinsurance on some physician-administered (Part B) drugs during specific quarters, depending on price trends. Part D beneficiaries benefit indirectly as plans face less pressure from rapid price increases.

  • Do this: If you receive Part B drugs (for example, infusions in a clinic), ask your provider’s billing staff whether any inflation-adjusted coinsurance applies in 2026.
  • Plan ahead: Don’t count on rebates for specific savings—they vary by drug and quarter—but consider them a protective backstop against price spikes.

What seniors should do to prepare for 2026

Make a personalized medication and care inventory. List every drug with dose, frequency, and preferred pharmacies; include any physician-administered Part B drugs. This ensures accurate comparisons and helps your doctor suggest lower-cost alternatives if needed.

  • Compare plans during open enrollment. Use the Medicare Plan Finder to check premiums, deductibles, copays, and pharmacy networks for 2026. Pay close attention to whether your drugs are on-formulary and to any utilization rules (prior auth, step therapy).
  • Consider the monthly “smoothing” option. If big refills strain your budget, ask your 2026 Part D plan how to opt in to the Prescription Payment Plan and how it works with the $2,000 cap.
  • Check Extra Help (LIS) eligibility. Many more people now qualify for full help with Part D premiums and cost sharing. Apply through Social Security’s Extra Help (Low-Income Subsidy) to see if you can cut costs dramatically.
  • Review your plan’s Annual Notice of Change. Look for premium or formulary changes, pharmacy network shifts, and any updates tied to the 2026 redesign.
  • Talk to your clinicians. Ask if lower-cost therapeutic alternatives are appropriate, especially if your current drug isn’t among the negotiated products.

Key dates and reminders

  • Oct 1: Plans begin sending Annual Notice of Change (ANOC).
  • Oct 15–Dec 7: Medicare Open Enrollment for 2026 coverage.
  • Jan 1, 2026: New plan year starts; negotiated prices for selected drugs and all 2026 program changes take effect.
  • Jan 1–Mar 31, 2026: Medicare Advantage Open Enrollment Period (switch MA plans or return to Original Medicare with/without Part D).

Frequently asked questions

Will my plan automatically enroll me in the monthly payment (smoothing) program?

No. It’s generally an opt-in feature. Contact your Part D plan to enroll and ask about billing, missed payment policies, and how changes in therapy affect your monthly amount.

Could my premiums still rise even with the growth limits?

Yes. The law limits growth in the base premium benchmark, but individual plan premiums can still vary. That’s why it’s essential to compare plans every year.

How do I know if my drug is one of the negotiated products?

Watch for CMS announcements and check your plan’s 2026 formulary and cost estimator. If your drug isn’t included, ask your doctor if a negotiated alternative could work for you.

Sources